Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: AIDS Behav. 2018 Sep;22(9):3009–3023. doi: 10.1007/s10461-018-2103-8

Table 3.

Distance to care, demographic and clinical characteristics of DC Cohort participants residing in clusters of low retention-in-care (RIC), low viral suppression (VS) and high VS in Washington, DC 2014-2015.

Participants residing in cluster of
neighboring ZIP-codes with low RIC
N=3,623
Participants residing in cluster of
neighboring ZIP-codes with low VS
N=2,568
Participants residing in cluster of
neighboring ZIP-codes with high VS
N=2,568
In cluster Not in cluster p-value In cluster Not in cluster p-value In cluster Not in cluster p-value
45 (1.2) 3,578 (98.8) 811 (31.6) 1,757 (68.4) 32 (1.2) 2,536 (98.8)
Distance ≥5 miles
 No 45 (100) 3,128 (87.4) <0.01 743 (92.4) 1,576 (90.0) <0.05 31 (96.9) 2,288 (90.7) 0.22
 Yes 0 (0) 450 (12.6) 61 (7.6) 176 (10.0) 1 (3.1) 236 (9.3)
 Median (IQR) 0.6 (0.2, 2.3) 3.1 (1.6, 4.5) <.0001 3.2 (2.5, 4.5) 2.3 (1.2, 4.0) <.0001 2.1 (0.6, .0) 2.8 (1.6, 4.2) <0.01
Retained 29 (64.4) 2,609 (72.4) 0.18 843 (74.1) 1,808 (72.8) 0.40 NA NA NA
VS 26 (57.8) 1,955 (54.6) 0.67 585 (72.1) 1,396 (79.5) <0.0001 30 (96.8) 1,951 (84.6) 0.06
Age as of June 2015
 Median (IQR) 52 (47-61) 50 (40-57) 0.12 51 (43-58) 51 (42-58) 0.83 51 (42, 58) 53 (44, 62) <0.001
Sex at birth
 Male 42 (93.3) 2,467 (68.9) <0.001 523 (64.5) 1,284 (73.1) <0.001 30 (93.7) 1,777 (70.1) <0.01
 Female 3 (6.7) 1.111 (31.1) 288 (35.5) 473 (26.9) 2 (6.3) 759 (29.9)
Race/ethnicity3
 Hispanic 4 (8.9) 147 (4.1) <.0001 15 (1.8) 99 (5.6) <.0001 4 (12.5) 110 (4.3) <0.0001
 NH Black 9 (20.0) 2,969 (83.0) 752 (92.7) 1,397 (79.5) 12 (37.5) 2,137 (84.3)
 NH White 28 (62.2) 406 (11.3) 37 (4.6) 232 (13.2) 15 (46.9) 254 (10.0)
 Other/Unknown 4 (8.9) 56 (1.6) 7 (0.9) 29 (1.7) 1 (3.1) 35 (1.4)
Housing
 Permanent 42 (93.3) 2,765 (77.3) 0.04 615 (75.8) 1,335 (76.0) 0.99 26 (81.2) 1,924 (75.9) 0.51
 Homeless/Unstable 1 (2.2) 367 (10.3) 89 (11.0) 194 (11.0) 4 (12.5) 279 (11.0)
 Other/Unknown 2 (4.4) 446 (12.5) 107 (13.2) 228 (13.0) 2 (6.3) 333 (13.1)
Employment status4
 Employed 21 (46.7) 829 (23.2) <.001 131 (16.2) 355 (20.2) <.0001 8 (25.0) 478 (18.9) 0.23
 Unemployed 5 (11.1) 1,218 (34.0) 317 (39.1) 523 (29.8) 6 (18.7) 834 (32.9)
 Other 19 (42.2) 1,531 (42.8) 363 (44.8) 878 (50.0) 18 (56.3) 1,224 (48.3)
HIV Risk5
 MSM 35 (77.8) 1,727 (48.3) <0.101 315 (38.8) 916 (52.1) <.0001 24 (75.0) 1,207 (47.6) <0.01
 IDU 3 (6.7) 600 (16.8) 185 (22.8) 185 (22.8) 2 (6.3) 752 (29.7)
 Heterosexual 6 (13.3) 1,093 (30.5) 278 (34.3) 476 (27.1) 4 (12.5) 475 (18.8)
 Other/unknown 1 (2.2) 158 (4.4) 33 (4.1) 71 (4.0) 2 (6.2) 99 (3.9)
Primary insurance type6
 Private 27 (55.6) 733 (20.5) <.0001 99 (12.2) 302 (17.2) <0.001 13 (40.6) 388 (15.3) <0.001
 Public 19 (42.2) 2,655 (74.2) 679 (83.7) 1,355 (77.1) 19 (59.4) 2,015 (79.5)
 Other/Unknown 1 (2.2) 190 (5.3) 33 (4.1) 100 (5.7) 0 (0) 133 (5.2)
Clinic type
 Hospital 30 (66.7) 1,437 (40.2) <0.001 237 (29.2) 549 (31.2) 0.30 16 (50) 770 (30.4) <0.05
 Community 14 (33.3) 2,141 (59.8) 574 (70.8) 1,207 (68.8) 16 (50) 1,766 (69.6)
Primary care at site
 Yes 27 (60.0) 2,761 (78.2) <0.01 695 (86.9) 1,495 (86.0) 0.54 25 (78.1) 2,165 (86.4) 0.18
 No 18 (40.0) 768 (21.8) 105 (13.1) 244 (14.0) 7 (21.9) 342 (13.6)
History of AIDS
 Yes 23 (51.1) 2,236 (62.5) 0.12 520 (64.1) 1,123 (63.9) 0.92 21 (65.6) 1,622 (65.6) 0.85
 No 22 (48.9) 1,342 (37.5) 291 (35.9) 634 (36.1) 11 (34.4) 914 (34.4)

NOTE: NH=non-Hispanic; MSM = men who have sex with men; IDU = injection drug user; IQR = interquartile range. P-values were computed using Pearson (goodness of fit) χ2statistics for categorical variables and using t-tests for equal variances for continuous variables. For all tests, p-values were considered statistically significant at the 0.05 alpha level.

1

RIC was defined as evidence of ≥ 2 HIV-related clinical encounters and/or HIV-related labs ≥90 days apart in 12 months.

2

Viral suppression (VS) was defined as viral load <200 copies/mL at last visit among those retained in care and prescribed antiretroviral therapy.

3

Other race groups include those belonging to more than race group and unknown.

4

Other includes retired, student, disabled, termination of student, unknown, and other.

5

MSM risk includes persons identified as having both MSM and IDU risk.

6

Primary insurance type was either public (Medicare, Medicaid, Ryan White/ADAP, or DC Alliance) or private (commercial payer).